FEDERATED HERMES, INC. - IRONWOOD PHARMACEUTICALS INC ownership

IRONWOOD PHARMACEUTICALS INC's ticker is IRWD and the CUSIP is 46333X108. A total of 205 filers reported holding IRONWOOD PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.2%.

Quarter-by-quarter ownership
FEDERATED HERMES, INC. ownership history of IRONWOOD PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$11,321
+52.6%
1,064
+50.9%
0.00%
Q1 2023$7,417
-13.6%
705
+1.7%
0.00%
Q4 2022$8,586
-57.1%
693
-64.8%
0.00%
Q3 2022$20,000
-45.9%
1,967
-37.9%
0.00%
Q2 2022$37,000
-97.7%
3,166
-97.6%
0.00%
-100.0%
Q1 2022$1,639,000
-71.9%
130,250
-74.0%
0.00%
-63.6%
Q4 2021$5,840,000
-10.6%
500,819
+0.1%
0.01%
-8.3%
Q3 2021$6,533,000
+5.6%
500,200
+4.0%
0.01%0.0%
Q2 2021$6,188,000
+13.6%
480,775
-1.4%
0.01%
+9.1%
Q1 2021$5,449,000
-4.9%
487,388
-3.1%
0.01%
-8.3%
Q4 2020$5,727,000
+27.0%
502,747
+0.3%
0.01%
+9.1%
Q3 2020$4,510,000
-25.8%
501,341
-14.8%
0.01%
-26.7%
Q2 2020$6,076,000
+3.4%
588,717
+1.1%
0.02%
-11.8%
Q1 2020$5,874,000
-12.7%
582,170
+15.1%
0.02%
+13.3%
Q4 2019$6,731,000
+227.5%
505,685
+354.3%
0.02%
+200.0%
Q3 2018$2,055,000
+244.8%
111,310
+218.5%
0.01%
+150.0%
Q1 2017$596,00034,9510.00%
Other shareholders
IRONWOOD PHARMACEUTICALS INC shareholders Q2 2020
NameSharesValueWeighting ↓
Sarissa Capital Management LP 16,390,000$172,422,80022.05%
13D Management LLC 533,562$5,613,0732.85%
Quantedge Capital Pte Ltd 541,200$5,693,4242.22%
Price Jennifer C. 520,000$5,470,4001.74%
Tamarack Advisers, LP 210,000$2,209,2000.81%
Intrinsic Value Partners, LLC 51,605$542,8850.73%
Brown Capital Management 3,933,933$41,384,9750.62%
Old West Investment Management, LLC 75,219$791,3030.43%
EMC Capital Management 43,315$4560.38%
Hillsdale Investment Management Inc. 420,617$4,424,8910.38%
View complete list of IRONWOOD PHARMACEUTICALS INC shareholders